VB100 Healthcare Industry Development Index Phase I Concludes: One Report and Three Roundtables Unveil the 'Trend Line' for China's Healthcare Sector Outlook Over the Next Six Months

China’s medical industry clusters exhibit distinct regional distribution characteristics. Traditional medical industrial parks are evolving into regional industry clusters, making a high-quality industrial development ecosystem particularly crucial for enterprises.

Over the past month or so, VCBeat and VCBeat jointly proposed“VB100 Medical Industry Development Index”and launched relevant research activities, inviting more than 1,000 innovative entrepreneurs to participate. Ultimately, we received insights and judgments from 514 entrepreneurs regarding their companies’ expected revenue, financing plans, market launch strategies, hiring needs, and intended regions for development over the next six months. These industry data, drawn from five major sectors—medical devices, pharmaceuticals and contract outsourcing, private healthcare service providers, distribution channels and e-commerce, and digital health and digital wellness—cover listed companies as well as leading, medium-sized, and small non-listed companies, constituting“Trend Line” for the Development Outlook of China’s Healthcare Industry in the Next Six Months。

Based on the above background,May 12–14, 2020: VCBeat’s VB100 Healthcare Industry Development Index Activity Week kicked off. Through one “2020 VB100 Healthcare Industry Development Index Report” and three roundtable discussions, we dissected the VB100 Healthcare Industry Development Index for our audience.。

Quantitative data can promptly reflect industry changes and facilitate a comprehensive assessment of the healthcare sector. We aim to develop the VB100 Development Index, leveraging the VCBeat VB100 rankings and corporate expectation surveys, to generateChina's First Macro "Trend Line" Reflecting the Development Expectations of the Medical Industry in the Next Half Year, providing quantitative support for government decision-making, corporate strategy, and industrial development research.

This report analyzes the Medical Industry Development Confidence Index across specialized sectors and regional industrial clusters. The following are the core insights of the report:

1. In the first half of 2020, 36% of companies in the healthcare industry expected their revenue to maintain growth,Channel Distribution and Digital Health Sector Expected to See Higher Growth Rates；

2. Affected by the pandemic, companies were more cautious with their marketing budgets in the first half of the year; 69% of companies reduced or maintained their advertising budgets.Healthcare IT CompaniesRelatively high willingness to invest;

3. Among the indicator companies,73% of Enterprises Have Financing Plans in the Next Six Months, startups may face a financing boom in the second half of the year;

4. We have categorized the geographical distribution of China's healthcare industry into three industrial belts and 14 urban industrial clusters. In the first half of the year,Highest Confidence Index in Eastern Coastal Industrial Belts, the industrial belt in the middle reaches of the Yangtze River is relatively weak, while the western industrial belt may rise;

5. Beijing boasts a rich pool of innovative enterprises, continuously expanding into the Yangtze River Delta, the Pearl River Delta, and the Western Economic Circle, thereby providing liquidity for the in-depth development of industries.

Scan the QR code to access the full report

According to the “2020 VB100 Healthcare Industry Development Index Report” by VCBeat Research Institute, Beijing, Shanghai, and Shenzhen have remained consistently dynamic in the course of regional development flows. Why do regions such as the Yangtze River Delta economic circle, the Pearl River Delta economic circle, and the Beijing-Tianjin-Hebei economic circle continue to be the primary target areas for healthcare industry development? What are the advantages of the industrial ecosystems in these economic circles? This year’s VB100 Healthcare Industry Development Index Week has also invitedGaochun, Jiangsu; Tianjin Economic-Technological Development Area; Guangdong Medical ValleyParticipated in a roundtable discussion as a representative of the regional industrial cluster.

Gaochun, Jiangsu, draws its strength from R&D innovation and leverages a suite of supporting service platforms—known as the “One Institute and Six Centers”—including the Gaochun Branch of the Jiangsu Medical Device Testing Institute, a Product Exhibition Center, a Medical Device Innovation Service Center, a Medical Device Waste Disposal Center, a Big Data Center for Medical Device Operation Monitoring, and a Sterilization Center, all working together to drive the development of the medical industry.

Tianjin Economic-Technological Development Area: Digital healthcare construction under the “TEDA Model” takes a key step forward, exploring solutions to a batch of new issues through innovations in tax systems and regulatory approachesDevelopment Challenges Facing Economic Enterprises. With the support of digitalization, Tianjin has achieved a "double victory" in both epidemic prevention and control and economic and social development. Recently, the Tianjin Economic-Technological Development Area was selected as one of the first national bases for digital service exports, signaling that Tianjin’s digital healthcare industry has embarked on a fast track of development.

Leveraging the synergistic development policies of the National New Area and the Pilot Free Trade Zone, Guangdong Medical Valley is building an International Medical Industry Innovation Center. By continuously strengthening support in talent, technology, capital, and resources, and based on a thorough understanding of the medical industry ecosystem, it has established a comprehensive supporting service system. This includes designing hardware facilities tailored to the medical industry and providing one-on-one services to enterprises through seven major service platforms.

As can be seen, a high-quality industrial ecosystem features comprehensive supporting services and complete innovation elements.SouthWu Teng, Deputy General Manager of Jingyou Debang Medical Technology Co., Ltd.; Chao Bo, Director of Government Affairs at LinkDoc Technology; Wei Dong, CEO of Ediacare Biotechnology; and Xu Ce, Chief Financial Officer of Genetron Health (Beijing) Technology Co., Ltd.They also expressed their understanding and expectations for a high-quality industrial ecosystem.

Click the link below to watch more exciting content

Jiangsu Gaochun: Driving Medical Industry Development Through Innovation

Tianjin ETDZ: Innovating the “TEDA Model” for the Digital Healthcare Industry Under the Institutional Empowerment Advantages of the Free Trade Zone

Guangdong Medical Valley: “Dual-Zone Synergy” to Build a World-Class Medical Industry Innovation Center

The VB100 Development Index series, an online initiative launched by VCBeat and Eggshell Research Institute, aims to explore trends in industrial innovation and analyze the evolution of the healthcare sector from regional markets to a national scale in China. Centered on the release of the VB100 Development Index Report, the initiative will feature a range of activities, including online surveys, VB group interviews, VB Roundtable discussions, and the VB100 Online Forum.

The first phase of the VB100 Development Index series was launched in March. Following extensive planning and research, initial findings were shared from May 12–14, 2020. We will continue to explore the demands of high-value, influential industry sectors, enrich the core index portfolio, and update the VB100 Development Index on a semiannual basis. The next index release is scheduled to commence in September.

Follow the official website of the VB100 Development Index series to get the latest updates,https://vcbeat.top/Forum/vbindex